Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Teerlink

Showing results (11-20 of 351) with videos related to

Pageof 36
Sort By:
American Heart Journal|February 21, 2003
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failureJohn R Teerlink
Journal of Cardiac Failure|December 15, 2022
HFSA: Serving Those Who Serve Heart Failure PatientsJohn R Teerlink
Current Cardiology Reports|April 19, 2002
The role of endothelin in the pathogenesis of heart failureJohn R Teerlink
Journal of Cardiac Failure|April 14, 2023
Nurturing the Future of Heart Failure: The HFSA Advanced Heart Failure and Transplant Cardiology Task ForceJohn R Teerlink
Current Opinion in Cardiology|April 21, 2004
A rational approach for the treatment of acute heart failure: current strategies and future optionsMadan Sharma, John R Teerlink
JACC. Heart Failure|September 13, 2015
Screening for Sleep-Disordered Breathing in Patients Hospitalized for Heart FailureOlaf Oldenburg, John R Teerlink
Lancet (London, England)|May 28, 2013
Not time to RELAX in acute heart failure - Authors' replyJohn R Teerlink, Marco Metra,
Heart (British Cardiac Society)|November 26, 2015
Serelaxin and acute heart failureJeremy Tietjens, John R Teerlink
European Heart Journal|March 11, 2011
Cardiac inotropes: current agents and future directionsGerd Hasenfuss, John R Teerlink
Lancet (London, England)|May 3, 2017
Heart failureMarco Metra, John R Teerlink
Pageof 36

Showing results (11-20 of 351) with videos related to

Sort By:
Pageof 36
American Heart Journal|February 21, 2003
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failureJohn R Teerlink
Journal of Cardiac Failure|December 15, 2022
HFSA: Serving Those Who Serve Heart Failure PatientsJohn R Teerlink
Current Cardiology Reports|April 19, 2002
The role of endothelin in the pathogenesis of heart failureJohn R Teerlink
Journal of Cardiac Failure|April 14, 2023
Nurturing the Future of Heart Failure: The HFSA Advanced Heart Failure and Transplant Cardiology Task ForceJohn R Teerlink
Current Opinion in Cardiology|April 21, 2004
A rational approach for the treatment of acute heart failure: current strategies and future optionsMadan Sharma, John R Teerlink
JACC. Heart Failure|September 13, 2015
Screening for Sleep-Disordered Breathing in Patients Hospitalized for Heart FailureOlaf Oldenburg, John R Teerlink
Lancet (London, England)|May 28, 2013
Not time to RELAX in acute heart failure - Authors' replyJohn R Teerlink, Marco Metra,
Heart (British Cardiac Society)|November 26, 2015
Serelaxin and acute heart failureJeremy Tietjens, John R Teerlink
European Heart Journal|March 11, 2011
Cardiac inotropes: current agents and future directionsGerd Hasenfuss, John R Teerlink
Lancet (London, England)|May 3, 2017
Heart failureMarco Metra, John R Teerlink
Pageof 36